🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Effect of PCI on Clinical Prognosis of Chronic Coronary Artery Occlusion

Recruitingn/aAges 18 Years - 75 YearsAllThe First Affiliated Hospital with Nanjing Medica…
NCT06542653 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Coronary chronic total occlusions (CTOs) are considered to increase the risk of adverse clinical outcomes. The purpose of this study was to evaluate whether long-term clinical outcomes could be improved by successful percutaneous coronary intervention (PCI) over optimal medical therapy (OMT) in CTO patients.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients with at least one coronary CTO lesion at our hospital in between January 2011 and December 2017 Exclusion Criteria: * (1) patients with ST-segment elevation myocardial infarction (STEMI) * (2)a history of coronary artery bypass grafting (CABG) * (3) cardiogenic shock * (4) malignant tumor. Patients were referred for PCI based on CTO-related symptoms or evidence of viability, or corresponding ischemia in the area of the CTO artery.
💊

What it tests

  • PCI
  • OMT
📍

Where

1 site
The First Affiliated Hospital with Nanjing Medical University
Nanjing, China
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy